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HGF and TIMP-4 expression. Expression of IL-6, IL-10, TNF-a, VEGF,
TGF-b, HA production and gene expression of HA synthases were not
differently modulated by the two different preparations. IL-4 and IL-13
gene expression levels were not detectable. IL-1 and IL-8 expression
levels showed a dose-response effect to L-PRP and signiﬁcantly corre-
lated with WBC count.. HGF expression showed an inverse correlation
with both WBC and platelet count. MMP-13 expression inversely corre-
lated with WBC number, whereas TIMP-4 inversely correlated with
platelet count. HAS-2 and HAS-3 had respectively direct and inverse
correlation trends with WBC count.
Discussion and Conclusions: Our data indicate that L-PRP is able to sus-
tain long-term up-regulation of pro-inﬂammatory factors, such as IL-1b,
IL-8 and FGF-2 compared to P-PRP, together with a down modula-
tion of HGF and TIMP-4 expression, two factors that have been rec-
ognized as anti-catabolic mediators in cartilage. Further researches
are needed to clarify the inﬂuence of different concentrations of
WBC on the bioactivity of PRP and their potential beneﬁcial effect.
Since WBC-platelet interaction may promote the biosynthesis of other
factors that facilitate the resolution of inﬂammation the optimization
of their concentrations in PRP products might lead to minimizing or
avoiding the detrimental effects ascribed to leucocytes and exploit
their beneﬁcial properties.
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Introduction: Engineering regenerative microenvironments and thera-
peutic biomolecules delivery are current challenges in wound healing.
Provisional wound matrices have a crucial role in tissue repair by acting
as a reservoir of growth factors and cytokines. Here, we investigated
the interactions between two of the most important extracellular
matrix molecules, namely ﬁbrinogen (Fg) and ﬁbronectin (FN), with
multiple growth factors and cytokines from various classes. Speciﬁc
growth factor- and cytokine- binding sites on Fg and FN have been
identiﬁed, and the importance of such interactions has been high-
lighted in vivo in a db/db diabetic mice wound-healing model.
Materials and methods: Heparin-binding domains of Fg and FN were
expressed in E.coli or HEK293 cells and puriﬁed by afﬁnity chromatog-
raphy. Binding afﬁnities were determined by ELISA or SPR analyses. In
vitro cells migration was measured by modiﬁed-Boyden chamber trans-
migration assay and time-lapse imaging. In vivo effect of engineered
matrices on wound healing was assessed in full-thickness excisional
skin wounds in db/db diabetic. Data signiﬁcances were determined by
Student t-test or ANOVA.
Results: More than ﬁfteen new promiscuous interactions were discov-
ered to occur through the heparin-binding domains of Fg and FN [1,2].
Based on these results, we have demonstrated that synthetic matrices
laden with ﬁbrinogen heparin-binding domain gained the ability to
fully mimic the reservoir function of ﬁbrin clot in vivo [2]. Moreover,
the co-delivery of ﬁbronectin with the cytokine CXCL11 was shown to
enhance in vitro keratinocyte migration (Fig. 1A), and to improve
re-epithelialization and wound closure in vivo when delivered in ﬁbrin
matrices (Fig. 1B) [3].
Discussion and conclusions: The reported results highlight the impor-
tance of interactions between ECM molecules and growth factors/cyto-
kines in the wound healing process. Such interactions are able to
strengthen the activities of therapeutic candidates, as CXCL11, and pro-
vide new avenues in designing smart regenerative microenvironments
for tissue repair.
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Introduction: Multifunctional dendrimers are emerging as promising
solutions to the current dilemma of drug delivery to the central nervous
system (CNS). Herein, we are proposing the use of carboxymethylchito-
san (CMCht)-grafted PAMAM dendrimer nanoparticles (NP) to provide
a targeted and sustained methylprednisolone (MP) release to CNS cells.
MP is widely used following neurotrauma and neuroinﬂammation,
however its actions are accompanied by deleterious effects. Despite
recent research on nanomedicine, basic knowledge on the interactions
of NP with living systems is still sparse. Thus, the interaction of MP-NP
with the astrocyte membrane and its intracellular trafﬁcking were
investigated using a new combination of techniques, namely patch--
clamp electrophysiology and live confocal imaging.
Figure 1 (A) Number of transmigrated keratinocytes, n = 6. (B) Wound
closure in db/db mice after full-thickness excisional skin defects, n = 8.
[3]
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Materials and methods: MP-loaded CMCht/PAMAM NP were synthe-
sized as reported.1,2 Primary astrocyte cultures were prepared from P3
Wistar rat newborns. For electrophysiology readings, cell-attached high
resolution membrane capacitance recordings were performed with a
two-phase lock ampliﬁer (SWAMIIB, Celica).3 Co-localization studies in
live astrocytes were done incubating AlexaFluor546 Dextran for endo-
some labeling, and transfecting mCherry-Neuropeptide Y for exocytotic
vesicle observation. Statistical signiﬁcance was assessed by one-way
ANOVAwith Bonferroni post-test.
Results: Differences in the frequency of astrocyte endocytosis and exo-
cytosis were observed in the presence of NP (Fig. 1). These differences
were more pronounced in the formation of exocytotic vesicles. More-
over, acute exposure to NP revealed larger endosomes, while the exocy-
tic vesicles had smaller diameters following NP incubation. Live
confocal imaging conﬁrmed NP trafﬁcking in astrocytes involves these
pathways, since co-localization of NP was observed associated to endo-
cytotic and exocytotic vesicles. Prolonged exposure of NP for a week
revealed continued co-localization with exosomes, while almost negligi-
ble endosomal transport.
Figure 1 Electrophysiology recordings of endocytic and exocytic vesicle
detection in the membrane.
Discussion and conclusions: It was conﬁrmed for the ﬁrst time the end-
ocytic and exocytic transport of MP-loaded CMCht/PAMAM dendrimer
NP. More importantly, NP were shown to be recycled and continuosly
cleared out from astrocytes via exocytosis one week after incubation,
unveiling its intracellular trafﬁcking pathways.
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Introduction: Nanoparticles have the potential to act as reservoirs for
the site speciﬁc targeted delivery of growth factors to aid the tissue
regeneration process. Details for the production of chitosan nanoparti-
cles by an emulsion technique [1] and the synthesis, uploading and
release of a BMP-2 mimic peptide are presented.
Materials and methods: Chitosan (CS) 1 % (w/v) in 1 % (v/v) acetic
acid was ﬁltered through a 0.8 lm pore membrane (Millipore) and
diluted (1:4) with methanol. Succinic anhydride (≥ 99 % GC, Sigma
Aldrich) dissolved in 5 ml acetone at 4 % (w/v) was added drop-wise
under magnetic stirring at 20 °C and left overnight. The gel formed
was removed, double diluted in methanol and dialysed against ultra-
pure water for 3 days. The precipitate was collected by centrifugation
and lyophilised (Suc-chi). Suc-chi (aq) (1 % w/v) was prepared and
mixed with liquid parafﬁn (910eq), homogenised for 30 minutes at
24,000 rpm, then Span 85 solution was added at 0.1 volume eq. and
homogenised again. 1 M NaOH solution (0.3 volume eq.) was then
added drop-wise and the solution homogenised, double diluted in tolu-
ene and washed by centrifugation (3,000 rpm). This was repeated
using ethanol and collected in water and lyophilised (SCB).
A BMP-2 peptide mimic NSVNSKIPKACCVPTELSAI [2] was synthes-
ised using a microwave solid phase synthesis system (Initiator, Biotage)
using 0.5 g Tentagel S resin. Initially, an Fmoc-Rink Amide linker was
coupled and sequential addition of x4 molar excess of each Fmoc-pro-
tected amino acid (0.4 mmole) using 0.4 mmoles HBTU and 0.8 mmo-
les DIPEA was performed. The peptide was cleaved from the resin
using triﬂuoroacetic acid: H2O: triisopropyl silane (95: 2.5: 2.5) and
precipitated in cold diethylether, then collected by centrifugation. SCB
(1 mg) produced were incubated for 2 h in 10, 5 and 1 lmole/ml of
BMP-2 mimic respectively. The nanobeads were centrifuged at
10,000 rpm for 5 minutes and the supernatant removed to determine
the loading of the nanobeads. The nanobeads were then re-suspended
in 1 ml PBS, transferred to dialysis tubing and placed in a shaking incu-
bator at 37 °C and the release of the BMP-2 mimic monitored over time
using UV spectroscopy at 280 nm.
Results: BMP-2 mimic was successfully synthesised (67% yield;
68.7 mg) as conﬁrmed by HPLC (retention time of 18 minutes) and
mass spectrometry (M2 + 1037.6 m/z). The emulsion technique pro-
duced SCB of 103  53 nm diameter, with a multimodal distribution.
The loading of SCB with BMP-2 mimic was found to be 0.68, 1.65 or
2.11 lmoles from 1, 5 and 10 lmoles solutions.
Discussion and conclusions: Release of BMP-2 mimic showed that
approximately 50% was still available after 5 days (Figure 1). The pro-
duction of a slow controlled release nanoparticle system for synthetic
growth factors will allow for the site speciﬁc targeted delivery of
growth factors for more effective regeneration of damaged tissue.
Figure 1 Dialysis release proﬁle of BMP-2 mimic from SCB at 37°C as
determined by UV spectroscopy at 280 nm.
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